The best research is enabled through collaboration. We work with a range of collaborators, including neuroscientists, biochemists, analytical chemists and clinicians. Currently active collaborators are listed below.
PROF Brett Garner
The Garner Group is located in the Illawarra Health and Medical Research Institute (IHMRI) in new laboratories that are well equipped for cell and molecular biology, analytical biochemistry, advanced microscopy and animal studies. A major goal of Prof Garner's group is to understand the regulation of brain lipid homeostasis and how this contributes to neurodegeneration. A strong emphasis is placed on the identification of novel therapeutic targets that modulate lipid parameters and oxidative stress with an ultimate goal to treat neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease.
A/prof ganesh anand
Based at the Nation University of Singapore, the Anand group research involves unraveling specific protein-protein, protein-ligand and protein-nucleic acid interactions. One of the areas of focus is the cyclic adenosine monophosphate (cAMP) signaling pathway. Other areas of interest include protein-nucleic acid interactions, intrinsically disordered proteins and development of small molecule inhibitors for drug discovery using structural mass spectrometry tools including Amide Hydrogen/Deuterium (H/D) Exchange Mass Spectrometry. The overall goal of our research is to map phosphorylation and ligand-dependent conformational changes at protein interfaces using multidisciplinary approaches integrating biophysics and structural biology with biochemistry
A/prof todd mitchell
- The role of lipids in the development of various pathologies including insulin resistance, obesity, cardiovascular disease and cataract
- Development of new mass spectrometric techniques for the analysis of lipids
dr lezanne ooi
- Use of induced pluripotent stem cells in neurodegenerative disease modelling and drug discovery.
- Effects of inflammation and oxidative stress on neuronal excitability and function.
- Identification of neuroprotective genes and drugs.
- Global control of gene expression and protein function: transcriptional regulation and epigenetics.
Dr Tony Palasovski
After receiving his general surgery fellowship in 2011, Dr. Palasovski completed prestigious fellowships in breast and endocrine surgery as well as in oncoplastic surgery. He is commited to developing a truly integrated breast service @ ISHC combining early detection & diagnosis, excisional and reconstructive surgery for patients with breast cancer. He has also previously published on Merkel cell skin cancer and is helping to deliver the innovative integrated skin cancer program in association with both the ISHC education and research foundation the NSW state government.